Psychological Evaluation in Rosacea Patients: A Case- Control Study using Symptom Checklist -90 - Revised
Abstract
Background: Rosacea, a prevalent chronic facial skin condition, is classically referred to as a “psychodermatosis”, in that psychological factors are relevant both in its initiation and course. Rosacea patients have been described as immature, anxious, with diminished self-esteem and with feelings of guilt and shame, or as psychoneurotic, with hysterical or obsessive compulsive configurations.
Objective: In this study we investigated the psychopathological distress experienced by rosacea patients, as compared to a group of dermatological patients suffering from acute, non-conspicuous, accidental dermatoses. One additional purpose was to assess the influence that demographic features and clinical factors had on final results.
Patients/Methods: A total of 243 patients with rosacea, aged from 18 to 72 years’ old were enrolled from an outpatient dermatology clinic in a hospital setting. Rosacea was objectively rated and disease duration recorded. The SCL-90 (R) was used to assess participants psychological distress and to record emotional and psycho vegetative complaints.
Results: Statistical analysis revealed a definite independent influence of the variables rosacea, gender, school level, and also of the interaction rosacea/gender on the psychometrical variables. Rosacea patients scored higher than controls with respect to interpersonal sensitivity (F[1,241]=3.57, p<0.01). Concerning gender differences, female patients scored always higher than controls in anxiety, depression, interpersonal sensitivity, obsession-compulsion, paranoid ideation and somatization, whereas male patients did so only for interpersonal sensitivity. As to the effects of disease duration, rosacea patients’ for more than one year revealed significantly higher scores of paranoid ideation than patients’ with less than one year duration (F[2,52]=3.79, p<0.05).
Conclusions: Patients suffering from rosacea – as opposed to other dermatoses – do experience significant psychosocial distress, which was nevertheless found to be unrelated to disease clinical sub-type.
Downloads
References
Plewig G, Kligman AM. Rosacea. In: Plewig G, Kligman AM, editors. Acne and Rosacea. Berlin: Springer Verlag; 2000. p.456-67.
Berg M, Liden S. An epidemiological study of rosacea. Acta Dermatol Venereol.1989; 69: 419-23.
Drake L. Survey maps typical progression from rosacea’s first appearance. Rosacea Revi.1995:2.
Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: Report of the national Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002; 46:584-7.
Powell C: Rosacea. N Engl J Med, 2005; 352:793-803.
Darwin C. The expression of the emotions in man and animals (1872). In: Porter DM, Graham PW, editors New York: Penguin Books: 1993.p. 364-93.
Buss AH. Self-consciousness and Social Anxiety. San Francisco: Freeman; 1980.
Drott C, Claes G, Olsson-Rex L, Dalman P, Fahlén T, Göthberg G. Successful treatment of facial blushing by endoscopic transthoracic simpathectomy. Br J Dermatol. 1998; 138:639-43.
Sowinska-Gługiewicz I, Ratajczak-Stefanska V, Maleszka R. Role of psychological factors in course of the rosacea. Rocz Akad Med Bialymst. 2005; 50Suppl 1:49-53.
Klaber R, Wittkover E. The pathogenesis of rosacea. Br J Dermatol Syphil. 1939; 2: 501-19.
Sobye P. Aetiology and pathogenesis of rosacea. Acta Dermatol Venereol, 1950; 30:137-58.
Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, Shew KR, Bouloc A, et al.Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol. 2006; 45:111-5.
Gupta MA, Gupta AK, Chen SJ, Johnson AM. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the US National Center for Health Statistics from 1995 to 2002. Br J Dermatol, 2005;
:1176-81.
Cormia FE. Basic concepts in the production and management of the psychosomatic dermatoses-II. Br J Dermatol. 1951; 63:129-51.
Panconesi E. Psychosomatic Dermatology. In: Panconesi E, editors. Clinics in Dermatology Stress and Skin Diseases: Psychosomatic Dermatology. Philadelphia: JB Lippincott; 1984.p.131-3.
Derogatis LR, Lipman RS, Covi L. SCL-90: An Outpatient Psychiatric Rating Scale – Preliminary Report. Psychopharmacol Bull. 1973; 9:13-28.
Baptista A. A génese da perturbação de pânico: A importância dos factores familiares e ambientais durante a infância e a adolescência. [Dissertação de doutoramento,]. Porto: Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; 1993.
Koblenzer CS. Flushing reactions and rosacea. In: Koblenzer CS, editor. Psychocutaneous Disease. Orlando: Grune and Stratton; 1987.p. 230-7.
Grosshans E. Bilan des notions ètiologiques actuelles de la rosacée. J Agregés. 1977; 10:427-33.
Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968; 80:170-7.
Rebora A. Rosacea. J Invest Dermatol. 1987; 88(Suppl 3):569-605.
Wilkin JK. Rosacea: a review. Int J Dermatol. 1983;22:393-400.
Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1984; 130:359-62.
Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 1989; 281:66-72.
Spoendlin J, Voegel JJ, Jick SS, Meier CR. Migraine, triptans, and the risk of developing rosacea. A population-based study within the United Kingdom. J Am Acad
Dermatol, 2013; 69:399-406.
Caputa M, Perrin G, Cabanac M. Ecoulement sanguine reversible dans la veine ophtalmique: mecanisme de refroidissement sèlectif du cerveau humain. CR Acad Sci. 1978; 287:1011-4.
Wilkin JK. Heat, not caffeine, induces flushing in erythematotelangiectatic
rosacea. J Invest Dermatol 1979;73:310-2.
Wilkin JK. Quantitative assessment of alcohol-provoked flushing. Arch Dermatol. 1986; 122:63-5.
Kurkmoglu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol. 1991; 25:725-6.
Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993; 28:132-3.
Wollina U. Rhinophyma-unusual expression of simple-type keratins and S 100 A in sebocytes and abundance of VIP-receptor-positive dermal cells. Histol Histopathol.
; 11:111-5.
Fimmel S, Schnitger A, Glass E, Zouboulis CC. Keratinocyte-and sebocyte-derived factors modify UVB activity on endothelial cells: a possible mechanism for the development of vascular changes in rosacea. J Invest Dermatol Res. 2004; 122:A3.
Zouboulis CC. Acne vulgaris and rosacea. In: Granstein RD, Luger T, editor. Neuroimmunology of the Skin. Basic Science to Clinical Practice. Berlin: Springer-Verlag; 2009. p. 225-32.
Wilkin JK, Josephs JA. Infrared photographic studies of rosacea. Arch Dermatol. 1980; 116:676-8.
Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol. 1969; 100:683-91.
Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007; 13:975-80.
Bevins CL, Liu FT. Rosacea: skin innate immunity gone awry? Nat Med. 2007; 13:904-6.
Duman N, Ersoy Evans S, Atakan N. Rosacea and cardiovascular risk factors: a case-control study. J Eur Acad Dermatol Venereol. 2014; 28:1165-9.
Hua TC, Chung PI, Chen YJ, Wu LC, Chen YD, Hwang CY,et al.Cardiovascular comorbidities in patients with rosacea: A natiowide case-control study from Taiwan. J Am Acad Dermatol. 2015; 73:249-53.
Cotterill JA. Rosácea y enrojecimiento facial, hiperhidrosis. In: Grimalt F, Cotterill JA, editors. Dermatologia y Psiquiatria – Historias Clinicas Comentadas. Madrid: Biblioteca Aula Medica; 2002. p. 239-44.
Finlay AY, Ryan TJ. Disability and handicap in dermatology. Int J Dermatol. 1996; 35:305-11.
Jowett S, Ryan T. Skin disease and handicap: An analysis of the impact of skin conditions. Soc Sci Med. 1985; 20:425-9.
Bar LH, Kuypers BR. Behaviour therapy in dermatologic practice. Br J Dermatol. 1973; 88:591-8.
Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007; 57:213-21.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
